Article

Efficacy and Safety Evaluation of Arbidol in Patients with COVID-19

2022-04-26

Abstract excerpt

<h4>Background: </h4> The spread of COVID-19 continues, the mutation of SARS-COV-2 is still difficult to control, and the need for antiviral drugs to treat COVID-19 remains urgent. The use of arbidol in the treatment of COVID-19 is limited and controversial. Methods To clarify the efficacy of arbidol on COVID-19, we collected 25 cases and 178 related studies. We analyzed the treatment information of arbidol based...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 86753304-83ec-56dc-9e1c-c47086f8e837
DOI: 10.20944/preprints202204.0225.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Efficacy and Safety Evaluation of Arbidol in Patients with COVID-19DOI 10.20944/preprints202204.0225.v1Read

Comparative efficacy and safety of current drugs against COVID-19: A systematic review and network meta-analysisSemantic proximity Read

Multi-center, randomized controlled, open evaluation of efficacy and safety of Arbidol hydrochloride tablets in the treatment of influenza-like casesSemantic proximity Read

Treatment with Arbidol and Moxifloxacin in Ordinary and Severe Adult Patients Infected with COVID-19Semantic proximity Read

An Overview on Drug Evolution and Trials on Pandemic COVID-19 InfectionSemantic proximity Read

Discovery and Development of Safe-in-Man Broad-Spectrum Antiviral AgentsSemantic proximity Read

Bromhexine, for Post Exposure COVID-19 Prophylaxis: A Randomized, Double-Blind, Placebo Control TrialSemantic proximity Read

Bromhexine, for post exposure COVID-19 prophylaxis: A Randomized, Double-Blind, Placebo Control TrialSemantic proximity Read

Molecular Mechanisms of the Medicines for COVID-19Semantic proximity Read

Identification of drugs associated with reduced severity of COVID-19: A case-control study in a large populationSemantic proximity Read

Classification of the present pharmaceutical agents based on the possible effective mechanism on the COVID-19 infectionSemantic proximity Read

Sofosbuvir/ledipasvir in combination or nitazoxanide alone are safe and efficient treatments for COVID-19 infection: A randomized controlled trial for repurposing antivirals.Semantic proximity Read

Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart ReviewSemantic proximity Read